Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 30, 2022
Assets:    
Cash and cash equivalents $ 43,104 $ 80,485
Accounts receivable 4,753 3,793
Inventory 7,548 4,094
Other current assets 4,440 3,359
Total current assets 59,845 91,731
Property and equipment, net 57,826 51,157
Goodwill 14,559 8,051
Intangibles, net 15,241 8,994
Operating lease right-of-use asset, net 1,374 1,126
Other assets 72 279
Total Assets 148,917 161,338
Current Liabilities:    
Accounts payable and accrued expenses 17,027 11,204
Contingent Consideration 855
Operating lease liability 439 313
Deferred revenue 105 286
Total current liabilities 17,571 12,658
Long-term Liabilities:    
Convertible notes payable, net 43,347 43,731
Contingent Consideration 591
Operating lease liability 976 811
Promissory note payable 667
Other long-term liabilities 117 117
Total long-term liabilities 45,107 45,250
Total Liabilities 62,678 57,908
Commitments and Contingencies (Note 15)
Stockholders’ Equity    
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 125,000,000 shares authorized; 72,154,647 and 57,079,347 shares issued and outstanding at June 30, 2023 and June 30, 2022, respectively 72 57
Additional paid in capital 356,522 310,171
Accumulated deficit (270,355) (206,798)
Total Stockholders’ Equity 86,239 103,430
Total Liabilities and Stockholders’ Equity $ 148,917 $ 161,338